These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 16221090

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
    Fujita N, Sugimoto R, Ma N, Tanaka H, Iwasa M, Kobayashi Y, Kawanishi S, Watanabe S, Kaito M, Takei Y.
    J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
    [Abstract] [Full Text] [Related]

  • 23. Liver dysfunction in patients with acute myelogenous leukemia: studies on patients not infected with hepatitis C virus during intense therapy.
    Kawatani T, Tajima F, Ishiga K, Suou T, Kawasaki H.
    J Med; 1998 Jul; 29(1-2):45-56. PubMed ID: 9704292
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.
    Nanmoku K, Imaizumi R, Tojimbara T, Nakajima I, Fuchinoue S, Sakamoto N, Watanabe M, Teraoka S.
    Transplant Proc; 2008 Sep; 40(7):2382-5. PubMed ID: 18790241
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function.
    Azevedo HA, Villela-Nogueira CA, Perez RM, Segadas-Soares JA, Takahashi C, Gaburo N, Pessoa I, Coelho HS.
    J Nephrol; 2007 Sep; 20(5):609-16. PubMed ID: 17918148
    [Abstract] [Full Text] [Related]

  • 30. Chronic hepatitis ameliorates anaemia in haemodialysis patients.
    Lin YL, Lin CW, Lee CH, Lai IC, Chen HH, Chen TW.
    Nephrology (Carlton); 2008 Jun; 13(4):289-93. PubMed ID: 18331433
    [Abstract] [Full Text] [Related]

  • 31. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E, Jabłońska-Kaszewska I, Bielawski KP, Falkiewicz B.
    Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
    [Abstract] [Full Text] [Related]

  • 32. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
    Kaya S, Cetin ES, Aridogan BC, Arikan S, Demirci M.
    J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.
    Lemos LB, Perez RM, Matos CA, Silva IS, Silva AE, Ferraz ML.
    J Clin Gastroenterol; 2008 Feb; 42(2):208-11. PubMed ID: 18209594
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.